BIAL appoints Pierluigi Antonelli as Non-Executive Board Member

Porto, April 24, 2024 - BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurology, has announced the appointment of Pierluigi Antonelli, Fresenius Management Board member and Chairman & CEO of Fresenius Kabi, as a non-executive member of its Board of Directors. Antonio Horta-...

Related Keywords

Coted Ivoire ,Portugal ,Mozambique ,Panama ,Italy ,Switzerland ,Angola ,United States ,United Kingdom ,Porto ,Spain ,Germany ,Ivory Coast ,Pierluigi Antonelli ,Libera Universit ,Fresenius Kabi ,Antonio Horta Osorio ,Bristol Myers Squibb ,Angelini Pharma ,Merck Co ,Life Sciences ,Kellogg School Of Management ,Fresenius Management Board ,Generic Drugs ,Novartis Oncology ,Kellogg School ,Studi Sociali ,